Emergent BioSolutions falls on quarterly revenue decline

Emergent BioSolutions

04/03/2025 12:42

** Shares of drugmaker Emergent BioSolutions EBS.N fall 13.8% to $5.9 premarket

** The company posted Q4 revenue of $194.7 mln late on Monday, down from $276.6 mln a year ago

** It reported Q4 adjusted profit of 5 cents/share, versus a loss of 77 cents/share the previous year

     ** The stock has more than doubled in the past 12 months

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com;))